Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | €31.13B | 32.7x | 0.08 | €509.80 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.3% Upside | Upgrade to Pro+ | |
UCB | Brussels | Healthcare | Pharmaceuticals | €30.36B | 28.7x | 0.13 | €159.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.3% Upside | Upgrade to Pro+ | |
Tubize-Fin | Brussels | Healthcare | Pharmaceuticals | €5.60B | 62.6x | 27.56 | €125.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.5% Upside | Upgrade to Pro+ | |
Fagron | Brussels | Healthcare | Pharmaceuticals | €1.56B | 19.5x | 1.39 | €21.35 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ | |
Ion Beam Applications | Brussels | Healthcare | Healthcare Equipment & Supplies | €334.12M | 35.6x | 0.18 | €11.32 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyxoah | Brussels | Healthcare | Healthcare Equipment & Supplies | €225.98M | -3x | 0.09 | €6.12 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ONWARD Medical BV | Brussels | Healthcare | Healthcare Equipment & Supplies | €180.14M | -5.1x | -0.16 | €4.14 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyloris | Brussels | Healthcare | Pharmaceuticals | €162.96M | -25.2x | -0.44 | €5.76 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGFA Gevaert | Brussels | Healthcare | Healthcare Equipment & Supplies | €140.89M | -1.5x | 0.02 | €0.91 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | €53.03M | -0.8x | -13.17 | €0.97 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biocartis Group NV | Brussels | Healthcare | Healthcare Equipment & Supplies | €27.24M | -0.3x | €0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
European Medical Solutions | Brussels | Healthcare | Healthcare Providers & Services | €21.16M | 38.5x | 0.22 | €5 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | €18.64M | -3.1x | -0.05 | €0.45 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosenic | Brussels | Healthcare | Pharmaceuticals | €1.04M | -0x | -0 | €0.002 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | €373.06K | 0.7x | 0.03 | €0.06 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Personalized Nursing Services | Brussels | Healthcare | Healthcare Providers & Services | €245K | €0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |